title: Comparative Effectiveness in Terms of Treatment Discontinuation of Orodispersable Versus. Standard Oral Olanzapine Tablets in Non-Adherent Patients: Results from a 1-Year European Outpatient Observational Study.
authors.affiliation: Eli Lilly Holdings Limited, Windlesham, UK.
authors.forename: D
authors.initials: D
authors.lastname: Novick
authors.affiliation: Eli Lilly Australia Pty Ltd,, West Ryde, Australia.
authors.forename: W
authors.initials: W
authors.lastname: Montgomery
authors.affiliation: Eli Lilly & Company, Budapest, Hungary.
authors.forename: T
authors.initials: T
authors.lastname: Treuer
authors.affiliation: Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Aguado
authors.affiliation: Eli Lilly and Company Ltd, Bad Homburg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Kraemer
authors.affiliation: Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Haro